Tea flavonoids:: Bioavailability in vivo and effects on cell signaling pathways in vitro

被引:74
作者
Wiseman, S [1 ]
Mulder, T [1 ]
Rietveld, A [1 ]
机构
[1] Unilever Res Labs Vlaardingen, Unilever Hlth Inst, NL-3130 AC Vlaardingen, Netherlands
关键词
D O I
10.1089/152308601317203549
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The elucidation of the potential health benefits of tea beverage continues to be a focus of research in many laboratories. Beneficial effects of tea have been particularly evident in animal tumorigenesis models, with green and black tea frequently demonstrating similar effectivity. Human data are now emerging to support a beneficial role for tea in cardiovascular disease, but the data with respect to cancer risk at various sites remain inconclusive. The constituent flavonoids of green and black tea beverage are known to be potent antioxidants, and although this may be a major factor in explaining their biological activity, it appears that the gallated flavonoids in particular (e.g., epigallocatechin gallate and the gallated theaflavins) impact on a wide range of molecular targets that influence cell growth and more specifically pathways such as those involving angiogenesis. Data on the pharmacokinetic properties of tea flavonoids, primarily on the catechins and therefore related most closely to green tea, have provided indications of the plasma levels and circulating molecular forms that may be expected in humans following tea consumption. The structural complexity of black tea flavonoids, in particular the thearubigins, has hindered efforts to describe their bioavailability and to perform mechanistic studies. Recent studies on the effects of catechins and theaflavins on growth factor-, nuclear factor-kappaB-, and stress-mediated signal transductions are described in this review, where possible in relation to their bioavailability in vivo. These studies indicate that effects that may be relevant to both cancer and atherosclerosis are often observed at tea flavonoid levels that could realistically be encountered in vivo. However, more studies need to be performed using those molecular forms of tea flavonoids (methylated, sulfated, and glucuronidated conjugates) that are the major circulating species encountered following tea consumption. Such studies, combined with further human epidemiological and interventional data, should ultimately elucidate the full beneficial potential of tea beverage on human health.
引用
收藏
页码:1009 / 1021
页数:13
相关论文
共 68 条
  • [1] Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate
    Ahmad, N
    Cheng, PY
    Mukhtar, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (02) : 328 - 334
  • [2] Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor κB in cancer cells versus normal cells
    Ahmad, N
    Gupta, S
    Mukhtar, H
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 376 (02) : 338 - 346
  • [3] Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells
    Ahmad, N
    Feyes, DK
    Nieminen, AL
    Agarwal, R
    Mukhtar, H
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (24): : 1881 - 1886
  • [4] Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172)
    Ahn, HY
    Hadizadeh, KR
    Seul, C
    Yun, YP
    Vetter, H
    Sachinidis, A
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (04) : 1093 - 1104
  • [5] August DA, 1999, CANCER EPIDEM BIOMAR, V8, P709
  • [6] The chemistry of tea flavonoids
    Balentine, DA
    Wiseman, SA
    Bouwens, LCM
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 1997, 37 (08) : 693 - 704
  • [7] (-)-epigallocatechin-3-gallate inhibition of ultraviolet B induced AP-1 activity
    Barthelman, M
    Bair, WB
    Stickland, KK
    Chen, WX
    Timmermann, N
    Valcic, S
    Dong, ZG
    Bowden, GT
    [J]. CARCINOGENESIS, 1998, 19 (12) : 2201 - 2204
  • [8] Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
    Bergers, G
    Brekken, R
    McMahon, G
    Vu, TH
    Itoh, T
    Tamaki, K
    Tanzawa, K
    Thorpe, P
    Itohara, S
    Werb, Z
    Hanahan, D
    [J]. NATURE CELL BIOLOGY, 2000, 2 (10) : 737 - 744
  • [9] Blot WJ, 1996, EUR J CANCER PREV, V5, P425
  • [10] Angiogenesis inhibited by drinking tea
    Cao, YH
    Cao, RH
    [J]. NATURE, 1999, 398 (6726) : 381 - 381